SpaceX Lockup Release Schedule and Dates: 2026–2027 Prospectus Calendar

A market opened; a single date did not

The IPO created a market, not one universal sale date

When SpaceX became a public company, employees could finally watch a daily market price for the first time. It is natural to read that visibility as permission to sell. But a public quote did not make every pre-IPO share tradable at once. The final prospectus describes several layers that can stand between a holder and a transaction: the offering lockup or market-standoff agreement, an earnings-linked or fixed release point, federal resale rules, affiliate status, company policy, award settlement, and brokerage controls.

The controlling public schedule appears in the June 12, 2026 final prospectus. It divides the covered shares into more than one timetable: a 180-day schedule with releases during 2026, an extended schedule continuing through quarterly results in 2027, and a separate 366-day category without early-release provisions. Aerospace Wealth rechecked the SEC filing history through July 17, 2026 and found no filing after June 26 that replaced that prospectus schedule. The table below therefore presents the currently published release framework, while keeping each schedule and condition separate.

The 180-day schedule

The first schedule starts with earnings and steps through December 8

For shares governed by the 180-day schedule, the first potential release is event-based rather than tied to a date printed on the calendar. On or after the second full Nasdaq trading day following the public release of quarterly results for the quarter ended June 30, 2026, the prospectus permits up to 20% of the shares in that category to be transferred. It calls that point the First Earnings Release Date. A second tranche of up to 10% can release at the same time only if the reported closing price is at least 30% above the $135 offering price—$175.50—for at least five of the ten consecutive trading days ending on and including that earnings-release date.

The fixed-date sequence then permits up to another 7% on each of August 20, September 9, September 24, October 9, and October 24, 2026. Up to another 28% can release on or after the second full Nasdaq trading day following public results for the quarter ended September 30, 2026. December 8, 2026 is the final fixed point for this schedule, when all remaining shares in the category may be transferred under the lockup language. If every earlier tranche including the price-conditioned 10% released, the percentages leave 7% for December 8; if that conditional tranche did not release, they leave 17%. Those percentages describe the lockup schedule, not whether an individual lot is delivered, registered, cleared, or otherwise tradable.

The extended schedule

A second group continues through 2027 quarterly results

The prospectus places another identified group of shares under an extended schedule. For those shares, up to 20% can release on or after the second full Nasdaq trading day following public results for the quarter ended December 31, 2026. The next fixed point is March 18, 2027, for up to another 10%, followed by up to another 20% after results for the quarter ended March 31, 2027. May 17, 2027 permits up to another 10%, and June 12, 2027 permits up to another 20%. All remaining shares in this extended category can release on or after the second full trading day following public results for the quarter ended June 30, 2027.

That schedule is intentionally different from the 180-day schedule, and the prospectus also identifies a separate 366-day holder category that remains restricted until immediately after the close of trading on June 12, 2027, without early releases. The public filing therefore does not support an assertion that every employee share unlocks in December 2026 or that June 12, 2027 is universal. Before attaching a date to a holding, identify the signed agreement, the holder category, the share or award source, and any later written company communication that applies.

A special date that needs context

September 10 is an affiliate resale point, not another general tranche

The prospectus's public-sale availability table contains one date that is easy to misread. It lists September 10, 2026 as the earliest public-market sale date for up to approximately 59.1 million shares held by affiliates that were subject to the 180-day lockup and released from those restrictions before that date. That row reflects the interaction between contractual release and federal resale requirements; it is not another automatic 7% release for the broader employee population.

Affiliate status can bring Rule 144 conditions, including volume limitations, into the analysis even after a contractual lockup clears. The prospectus also describes exceptions and circumstances involving underwriter consent, directed shares, sell-to-cover transactions, gifts, certain transfers, and other arrangements. Those provisions need to be read with the actual agreement and current process, not converted into a shortcut. A transaction can be permitted under one layer and still be blocked under another.

• Confirm whether the holder is treated as an affiliate
• Separate contractual lockup release from Securities Act resale eligibility
• Confirm whether an exception requires consent or a replacement lockup agreement
• Retain the written company, compliance, transfer-agent, and brokerage instructions

Turn dates into an executable record

A lot is ready only when every restriction agrees on the same day

The practical calendar should have one row for every grant, purchase lot, or block of shares. Record the governing plan and agreement, how and when the shares were acquired, whether the award has vested or settled, which lockup schedule applies, the percentage or condition attached to the expected release, affiliate status, the current trading window, any preclearance, the brokerage restriction status, and the tax-basis record. Keeping those fields together prevents a corporate date from being mistaken for a personal authorization.

Recheck the file immediately before a proposed order. Confirm that the required earnings release actually occurred, count the two full Nasdaq trading days correctly where an event-based release applies, verify whether the price condition was met if it affects the lot, and obtain current company and brokerage clearance. Then preserve the approval, order instruction, execution confirmation, and tax-lot record together. The calendar is useful because it leads to that day-of-trade confirmation—not because a date printed months earlier can answer every question by itself.

This guide provides general education for SpaceX employees. It is not individualized financial, investment, tax, legal, benefits, or securities-law advice and is not a recommendation to buy, hold, sell, exercise, transfer, roll over, or donate an asset.

• Signed lockup or market-standoff agreement
• Applicable prospectus schedule and later SEC filings
• Award settlement or share-delivery confirmation
• Current trading-window and preclearance communication
• Affiliate and brokerage restriction status
• Lot-level basis and intended order instructions